FDA Limits Use of J&J's COVID-19 Vaccine Due to Blood Clot Risk

FDA Limits Use of J&J's COVID-19 Vaccine Due to Blood Clot Risk

Thursday, 05 May 2022 05:25 PM

https://www.newsmax.com/health/health-news/covid-vaccine-j-andj-fda/2022/05/05/id/1068685/?ns_mail_uid=3d1c60ea-5cf9-4620-a773-8f6870cf2e53&ns_mail_job=DM330654_05062022&s=acs&dkt_nbr=010502wn9e1k

The U.S. Food and Drug Administration (FDA) said on Thursday it was limiting the use of Johnson & Johnson's COVID-19 vaccine for adults due to the risk of a rare blood clotting syndrome.

The J&J shot is authorized for those aged 18 and above and is one of the three COVID-19 vaccines cleared for use in the United States.

The agency said the J&J shot can be administered in cases where authorized or approved COVID-19 vaccines are not accessible or if an individual is less keen on using the other two shots.

The FDA said its analysis had determined that the risk of thrombosis with thrombocytopenia syndrome after the administration of the shot warrants limiting of the authorization. J&J did not immediately respond to a Reuters request for comment. 

Connecting the Dots:

Charles O. Prince III is a director at Johnson & Johnson and was a trustee at the Brookings Institution (think tank).

Foundation to Promote Open Society was a funder for the Brookings Institution (think tank).

George Soros was the chairman for the Foundation to Promote Open Society.

Ann Dibble Jordan is an honorary trustee at the Brookings Institution (think tank) and was a director at Johnson & Johnson.

Mark B. McClellan was a senior fellow at the Brookings Institution (think tank), a commissioner for the U.S. Food and Drug Administration (FDA) and is a director at Johnson & Johnson.

Resources: Past Research

Johnson's Baby Powder and Ovarian Cancer (Past Research on Johnson & Johnson)

SUNDAY, APRIL 10, 2016

https://thesteadydrip.blogspot.com/2016/04/johnsons-baby-powder-and-ovarian-cancer.html